Mycobacterium cell wall-DNA Complex (ProMetic Life Sciences)

N/A

Report date: 2024/11/27 10:30:35

Base Information

Drug NameMycobacterium cell wall-DNA Complex (ProMetic Life Sciences)
Drug Alias NameMCNAMCCMCC/HAMycobacterium phlei cell-wall - nucleic acid complexMycobacterium Cell Wall-DNA Complex/hyaluronic acid +[9] 
ClassificationBiologics
Mechanisms of ActionInterleukin-6 stimulantsInterleukin-12 stimulants
TargetsInterleukin-12Interleukin-6
Therapy Area/IndicationsNeoplasm Recurrence, LocalUrinary Bladder NeoplasmsCarcinoma, Transitional Cell +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPrometic Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioniche Life Sciences Inc
Active IndicationsN/A
Inactive IndicationsNeoplasm Recurrence, LocalUrinary Bladder NeoplasmsCarcinoma, Transitional Cell +[5] 

Other Information

ATC CodeN/A
Related LinksN/A